Naoka Murakami

Dr. Naoka Murakami is a transplant nephrologist at Brigham and Women’s Hospital (BWH) in Boston, MA, USA. She graduated from MD-PhD program at University of Tokyo in Japan and completed internal medicine residency at Mount Sinai Beth Israel. She then finished BWH/MGH joint nephrology fellowship and transplant nephrology fellowship at BWH. Her primary research interest is kidney transplant tolerance and T cell immunology, especially the roles of immune checkpoint molecules in transplant and autoimmune kidney diseases. Her research has been supported by NIH and the American Society of Nephrology. In clinic, she is passionate about transplant onconephrology, with the ultimate goal of providing better care for kidney transplant recipients with cancer, with strong collaboration with oncologists at the Dana Faber Cancer Institute.

Dr. Murakami was named one of the ISN-KI Early Career Researchers for Clinical Science for her paper ‘A multi-center study on safety and efficacy of immune checkpoint inhibitors in cancer patients with kidney transplant.’